• Publications
  • Influence
Process-related risk of beryllium sensitization and disease in a copper-beryllium alloy facility.
BACKGROUND Chronic beryllium disease (CBD), which primarily affects the lungs, occurs in sensitized beryllium-exposed individuals. At a copper-beryllium alloy strip and wire finishing facility weExpand
  • 99
  • 10
Sensitization and chronic beryllium disease at a primary manufacturing facility, part 3: exposure-response among short-term workers.
OBJECTIVES Exposure-response relations for beryllium sensitization (BeS) and chronic beryllium disease (CBD) using aerosol mass concentration have been inconsistent, although process-related risksExpand
  • 30
  • 7
Major histocompatibility locus genetic markers of beryllium sensitization and disease.
Hypersensitivity to beryllium (Be) is found in 1-16% of exposed workers undergoing immunological screening for beryllium disease using the beryllium lymphocyte proliferation test (BeLPT). However,Expand
  • 83
  • 6
Enhanced preventive programme at a beryllium oxide ceramics facility reduces beryllium sensitisation among new workers
Background: A 1998 survey at a beryllium oxide ceramics manufacturing facility found that 10% of workers hired in the previous 6 years had beryllium sensitisation as determined by the berylliumExpand
  • 54
  • 5
Contribution of incidental exposure pathways to total beryllium exposures.
Beryllium manufacturing processes are associated with the immune-mediated chronic beryllium disease (CBO). Recent workplace epidemiological studies have been relatively unsuccessful in correlatingExpand
  • 28
  • 4
Exposure to Beryllium and Occurrence of Lung Cancer: A Reexamination of Findings From a Nested Case–Control Study
Objective: Our aim was to reanalyze a nested case–control study of beryllium and lung cancer because we identified analysis and study design issues that could have led to the elevated odds ratiosExpand
  • 35
  • 4
Sensitization and Chronic Beryllium Disease Among Workers in Copper–Beryllium Distribution Centers
Objective: Little is known about the risk of sensitization and chronic beryllium disease (CBD) among workers performing limited processing of copper–beryllium alloys downstream of the primaryExpand
  • 26
  • 4
Variability, predictive value, and uses of the beryllium blood lymphocyte proliferation test (BLPT): preliminary analysis of the ongoing workforce survey.
The beryllium blood lymphocyte proliferation test (BLPT) is used as a medical surveillance tool for assessment of persons at risk for developing clinical and subclinical chronic beryllium diseaseExpand
  • 56
  • 3
Beryllium sensitization, chronic beryllium disease, and exposures at a beryllium mining and extraction facility.
In this study, we examine beryllium sensitization, chronic beryllium disease (CBD), and workplace exposures at a beryllium mining (mine) and extraction facility (mill) in Delta, Utah. HistoricalExpand
  • 50
  • 3
Exposure pathway assessment at a copper-beryllium alloy facility.
Controlling beryllium inhalation exposures to comply with regulatory levels (2 micro g m(-3) of air) does not appear to prevent beryllium sensitization and chronic beryllium disease (CBD).Expand
  • 49
  • 2